Log In
BCIQ
Print this Print this
 

NRC-AN-019

  Manage Alerts
Collapse Summary General Information
Company Natco Pharma Ltd.
DescriptionOral receptor tyrosine kinase inhibitor
Molecular Target Receptor tyrosine kinase (RTK)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today